Diagnosis and treatment of renovascular hypertension: A cost-benefit analysis

American Journal of Roentgenology

Volumn 184, Issue 3, 2005, Pages 931-937

  Bolduc, Jean Philippe ^a   Oliva, Vincent L ^a   Therasse, Eric ^b   Giroux, Marie France ^a   Bouchard, Louis ^c   Perreault, Pierre ^c   Cliché, Andrée ^a   Soulez, Gilles ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; GADOLINIUM;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; CONVENTIONAL ANGIOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; KIDNEY SCINTISCANNING; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RENAL ARTERY; RENOVASCULAR HYPERTENSION; SCREENING TEST; STENOSIS; TREATMENT OUTCOME; COMPARATIVE STUDY; ECONOMICS;

AGED; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; PROSPECTIVE STUDIES;

EID: 16244373683     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.184.3.01840931     Document Type: Article

References (37)

1. World Health Organization (WHO) Expert Committee on Hypertension Control. Hypertension Control: Report of a WHO Expert Committee. Geneva, Switzerland: World Health Organization; 1996. WHO Technical Report Series, No. 862
2. Pardell H, Tresserras R, Armario P, Hernandez del Rey R. Pharmacoeconomic considerations in the management of hypertension. Drugs 2000;59[suppl 2]:13-20, discussion 39-40
3. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571-1576
4. Dustan HO, Rocella EJ, Garrison HH. Controlling hypertension: a research success story. Arch Intern Med 1996;156:1926-1935
5. Boudewijn G, Vasbinder C, Nelemans PJ, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001;135:401-411
6. Sos TA, Pickering TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983;309:273-279
7. von Knorring J, Edgren J, Lepäntalo M. Long-term results of percutaneous transluminal angioplasty in renovascular hypertension. Acta Radiol 1996;37:36-40
8. Helin KH, Tikkanen I, von Knorring JE, et al. Screening for renovascular hypertension in a population with relatively low prevalence. J Hypertens 1998;16:1523-1529
9. Working Group on Renovascular Hypertension. Detection, evaluation, and treatment of renovascular hypertension: final report. Arch Intern Med 1987;147:820-829
10. Morganti A, Bencini C, Del Vecchio C, Strata M. Treatment of atherosclerotic renal artery stenosis. J Am Soc Nephrol 2002;13[suppl 3]:S187-S189
11. Olin JW. Atherosclerotic renal artery disease. Cardiol Clin 2002;20:547-562
12. van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med 2000;342:1007-1014
13. Plouin PF, Chatelier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension 1998;31:823-829
14. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis: Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329-335
15. Prigent A. The diagnosis of renovascular hypertension: the role of captopril-enhanced renal scintigraphy and related issues. Eur J Nucl Med 1993;20:625-644
16. Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal artery stenosis. N Engl J Med 2001;344:410-417
17. Soulez G, Therasse E, Qanadli SD, et al. Prediction of renovascular hypertension: respective value of renal Doppler renal sonography and scintigraphy. AJR 2003;181:1029-1036
18. Kaplan NM. Renal vascular hypertension. In: Kaplan NM, ed. Clinical hypertension. Baltimore, MD: Williams and Wilkins; 1990:303-324
19. Androeli TE, Bennett JC, Carpenter CCJ, Plum F. Renovascular hypertension. In: Androeli TE, Carpenter CCJ, Griggs RC, Loscalzo J, eds. Cecil essentials of medicine, 4th ed. Philadelphia, PA: Saunders; 1997:228-229
20. Blaufox MD, Dubovsky EV, Hilson AJ, Taylor A Jr, de Zeeuw R. Report of the Working Party Group on Determining the Radionuclide of Choice. Am J Hypertens 1991;4[12 Pt 2]:747S-748S
21. Taylor AT Jr, Fletcher JW, Nally JV Jr, et al. Procedure guideline for diagnosis of renovascular hypertension: Society of Nuclear Medicine. J Nucl Med 1998;39:1297-1302
22. Martin LG, Rundback JH, Sacks D, et al. Quality improvement guidelines for angiography, angioplasty, and stent placement in the diagnosis and treatment of renal artery stenosis in adults. J Vasc Interv Radiol 2002;13:1069-1083
23. Rundback JH, Sacks D, Kent KC, et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2002;13:959-974
24. Blaufox MD, Middleton ML, Bongiovanni J, et al. Cost efficacy of the diagnosis and therapy of renovascular hypertension. J Nucl Med 1996;37:171-177
25. Frauchiger B, Zierler R, Bergelin RO, Isaacson JA, Strandness DE Jr. Prognostic significance of intrarenal resistance indices in patients with renal artery interventions: a preliminary duplex sonographic study. Cardiovasc Surg 1996;4:324-330
26. Ministry of Health and Social Services. www.msss.gouv.qc.ca/ documentation/normes_et_pratiques_de_gestion/2004-006. Accessed January 12, 2005.
27. Cohn EJ, Benjamin ME, Sandager GP, Lilly MP, Killewich LA, Flinn WR. Can intrarenal duplex waveform analysis predict successful renal artery revascularization? J Vasc Surg 1998;28:471-481
28. Geyskes GG, de Bruyn AJ. Captopril renography and the effects of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens 1991;4[12 Pt 2]:685S-689S
29. Postma CT, van Oijen AH, Barentsz JO, et al. The value of tests predicting renovascular hypertension in patients with renal artery stenosis treated by angioplasty. Arch Intern Med 1991;151:1531-1536
30. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality: the Framingham Heart Study 1950 to 1990. Circulation 1996;93:697-703
31. Dean RH, Kieffer RW, Smith BM, et al. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg 1981;116:1408-1415
32. Menard J. Cost-effectiveness of hypertension treatment. Clin Exp Hypertens 1996;18:399-413
33. American College of Radiology (ACR). ACR Radiology Coding Source. Available at: www.acr.org. Accessed January 5, 2004
34. Buxton MJ, Drummond MF, Van Hout BA, et al. Modelling in economic evaluation: an unavoidable fact of life. Health Econ 1997;6:217-227
35. Radermacher J, Brunkhorst R. Diagnosis and treatment of renovascular stenosis: a cost-benefit analysis. Nephrol Dial Transplant 1998;13:2761-2767
36. Carlos RC, Axelrod DA, Ellis JH, Abrahamse PH, Fendrick AM. Incorporating patient-centered outcomes in the analysis of cost-effectiveness: imaging strategies for renovascular hypertension. AJR 2003;181:1653-1661
37. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? a meta-analysis of randomized controlled trials. Am J Med 2003;114:44-50